150-cm Versus 200-cm Biliopancreatic Limb One-Anastomosis Gastric Bypass: Propensity Score-Matched Analysis
- PMID: 35804236
- DOI: 10.1007/s11695-022-06203-9
150-cm Versus 200-cm Biliopancreatic Limb One-Anastomosis Gastric Bypass: Propensity Score-Matched Analysis
Abstract
Background: It has been suggested that shortening the length of the biliopancreatic limb (BPL) to 150 cm in one anastomosis gastric bypass (OAGB) would reduce nutritional complication rates without impairing weight loss outcomes. The aim of this study is to compare patients who underwent OAGB with a 200-cm BPL (OAGB-200) to patients with OAGB with a 150-cm BPL (OAGB-150) in terms of weight loss and late morbidity.
Methods: This is a monocentric retrospective matched cohort study including patients with a body mass index between 35 and 50 kg/m2 who underwent an OAGB-150 or an OAGB-200. Patients were matched 1:1 based on age, sex, and body mass index, prior to bariatric surgery.
Results: In total, 784 patients who underwent OAGB were included (OAGB-150 n = 392 and OAGB-200 (n = 392). There was no significant difference in terms of early morbidity. Regarding late morbidity in patients with an OAGB-150, significantly lower rates for marginal ulcer (OR = 0.4, CI 95% [0.2; 0.8], p = 0.006), incisional hernia (OR = 0.5, CI 95% [0.3; 1], p = 0.041), and bowel obstruction (OR = 0.3, CI 95% [0.1; 0.9], p = 0.039) were reported. Likewise, regarding late nutritional deficiencies, post-OAGB-150, a significantly lower number of patients with hypoalbuminemia (OR = 0.3, CI 95% [0.2; 0.7], p = 0.006), low vitamin B9 (OR = 0.5, CI 95% [0.2; 1], p = 0.044), and low ferritin (OR = 0.5, CI 95% [0.3; 0.8], p = 0.005) were observed. There was no significant difference in the percentage of excess BMI loss at 1, 2, 3, 4, and 5 years.
Conclusion: Compared to OAGB-200 in patients with BMI ≤ 50 kg/m2, OAGB-150 results in fewer nutritional deficiency rates long term, without impairing weight loss.
Keywords: 150-cm biliopancreatic limb length; 200-cm biliopancreatic limb; Mini gastric bypass; Nutritional deficiencies; One-anastomosis gastric bypass; Weight loss.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Comment in
-
Reply to Letter to the Editor: France and One Anastomosis Gastric Bypass (OAGB): a "Witch Hunt".Obes Surg. 2022 Nov;32(11):3773-3774. doi: 10.1007/s11695-022-06263-x. Epub 2022 Sep 6. Obes Surg. 2022. PMID: 36068423 No abstract available.
-
France and One Anastomosis Gastric Bypass (OAGB): a "Witch Hunt".Obes Surg. 2022 Nov;32(11):3771-3772. doi: 10.1007/s11695-022-06262-y. Epub 2022 Sep 9. Obes Surg. 2022. PMID: 36083568 No abstract available.
References
-
- Angrisani L, Santonicola A, Iovino P, et al. similarities and disparities among the 5 IFSO Chapters. Obes Surg. 2018;2021:1–12. https://doi.org/10.1007/s11695-020-05207-7 . - DOI
-
- Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80. https://doi.org/10.1381/096089201321336584 . - DOI - PubMed
-
- Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25:951–8. https://doi.org/10.1007/s11695-014-1552-z . - DOI - PubMed
-
- Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet Lond Engl. 2019;393:1299–309. https://doi.org/10.1016/S0140-6736(19)30475-1 . - DOI
-
- Mahawar KK. Yet Another mortality with a biliopancreatic limb of > 200 cm with one anastomosis gastric bypass. Obes Surg. 2018;28:3634–5. https://doi.org/10.1007/s11695-018-3462-y . - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
